Articles

Home /Articles / FDA Federal Register Notices

No article fund in this category

Top News

Guidance Details Post-Approval Responsibilities for Generics
Stakeholders Press FDA to Pause Voucher Program Amid Transparency Concerns
House Passes $7.1 Billion FDA Spending Bill
FDA Rejects Xspray Pharma's Nilopki Application
FDA Breakthrough Device Designations Top 1,280
FDA Approves Lupin's Interchangeable Lucentis Biosimilar
Radiopharmaceutical Companies Want FDA Consistency
Supreme Court Sides With Generics in Skinny Label Dispute

FDA Webview Free Daily e-Newsletter

Free Sign-Up

Dickinson's FDA Webview is the interactive Web site that watches the U.S. Food and Drug Administration all day long. From the leading publisher of FDA-content business newsletters since 1984, you can monitor regulatory, legal, policy and scientific news affecting all FDA-regulated healthcare products and their marketing activities.